•  
  •  
 

Corresponding Author

Azhin D.Aziz

Document Type

Research Article

Abstract

Background and Objectives: in COVID-19 patients, secondary bacterial infections (SBIs) are a known complication of viral respiratory infections and are significantly associated with poorer outcomes.Our study aimed to determine the prevalence, clinical profile, antimicrobial resistance profile, and patient outcomes of secondary bacterial pneumonia and blood infections in COVID-19 hospitalized patients and their correlation with procalcitonin (PCT) levels.Method: During 7 months’ study, 260 clinical samples (blood and respiratory specimens) were collected from 130 hospitalized COVID-19 patients, of which 90 were from intensive care units (ICUs) and 40 from non-ICU departments, at six hospitals in Erbil city, Iraq. All samples were applied for bacterial identification via traditional method, Vitek-2 compact system, and molecular (PCR) detection. The antibiotic resistance profile was obtained via Vitek-2 compact system and the Standard International Kirby-Bauer disc diffusion method. Finally, the inflammatory biomarkers (PCT, C-reactive protein CRP, and WBC count) wereevaluated.Results: Among 130 patients, 64.16% were positive for SBIs, of which 86.9% from the ICU and 13.1% from the non-ICU department. The most prevalent isolates were gram-negative (77.7%) versus gram-positive (22.3%) bacteria. Klebsiella pneumoniae, Acinetobacter baumannii, and coagulase-negative staphylococci were the predominant isolates in both blood and respiratory specimen. There was an obvious relation between mortality rate and SBIs in the studied patients, which reached 81%. Most of the isolated bacteria, especially ICU isolates, were multidrug resistant. PCT increased in 79 (89.8%) of the patients with SBIs. The highest PCT level was found in patients with bloodstream infection.Conclusion: There is a high prevalence of bacterial superinfections in COVID-19 patients during hospitalization. Gram negative bacteria, especially Klebsiella pneumoniaeand Acinetobacter baumanniiwere the main bacteria, and the antimicrobial resistance rates against the major isolated bacteria were generally high. ThePCT level was positively associated with secondary bacterial infection and patient outcome..

Keywords

Covid-19, Secondary bacterial infections, Antibiotic resistance, ProcalcitoninRESE A RCHART I C L E

References

AHMED, S. S., MOHAMMED, D. A. & MOHAMMED, A. A. 2021. Hematological parameters in adult patients with COVID-19; A case-control study. International Journal of Infection, 8.

ALI, A. M., ROSTAM, H. M., FATAH, M. H., NOORI, C. M., ALI, K. M. & TAWFEEQ, H. M. 2022. Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients. Immunity, Inflammation and Disease, 10, e582.

ALQAHTANI, A., ALAMER, E., MIR, M., ALASMARI, A., ALSHAHRANI, M. M., ASIRI, M., AHMAD, I., ALHAZMI, A. & ALGAISSI, A. 2022. Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. International Journal of Environmental Research and Public Health, 19, 2424.

ATALLAH, N. J., WARREN, H. M., ROBERTS, M. B., ELSHABOURY, R. H., BIDELL, M. R., GANDHI, R. G., ADAMSICK, M., IBRAHIM, M. K., SOOD, R., BOU ZEIN EDDINE, S., COBLER-LICHTER, M. J., ALEXANDER, N. J., TIMMER, K. D., ATALLAH, C. J., VIENS, A. L., PANOSSIAN, V. S., SCHERER, A. K., PROCTOR, T., SMARTT, S., LETOURNEAU, A. R., PARAS, M. L., JOHANNES, S., WIEMER, J. & MANSOUR, M. K. 2022. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study. PLoS One, 17, e0262342.

BAKALETZ, L. O. 2017. Viral–bacterial co-infections in the respiratory tract. Current opinion in microbiology, 35, 30-35.

BALKHAIR, A., AL-MUHARRMI, Z., AL’ADAWI, B., AL BUSAIDI, I., TAHER, H., AL-SIYABI, T., AL AMIN, M. & HASSAN, K. 2019. Prevalence and 30-day allcause mortality of carbapenem-and colistinresistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decadelong trend. International Journal of Infectious Diseases, 85, 10-15.

BOORGULA, S. Y., YELAMANCHILI, S., KOTTAPALLI, P. & NAGA, M. D. 2022. An Update on Secondary Bacterial and Fungal Infections and Their Antimicrobial Resistance Pattern (AMR) in COVID19 Confirmed Patients. Journal of Laboratory Physicians, 14, 260-264.

BREWSTER, J. D. & PAOLI, G. C. 2013. DNA extraction protocol for rapid PCR detection of pathogenic bacteria. Analytical Biochemistry, 442, 107-109.

CARBONELL, R., URGELES, S., SALGADO, M., RODRIGUEZ, A., REYES, L. F., FUENTES, Y. V., SERRANO, C. C., CACERES, E. L., BODI, M., MARTIN-LOECHES, I., SOLE-VIOLAN, J., DIAZ, E., GOMEZ, J., TREFLER, S., VALLVERDU, M., MURCIA, J., ALBAYA, A., LOZA, A., SOCIAS, L., BALLESTEROS, J. C., PAPIOL, E., VINA, L., SANCHO, S., NIETO, M., DEL, M., LORENTE, C., BADALLO, O., FRAILE, V., ARMESTAR, F., ESTELLA, A., ABANSES, P., SANCHO, I., GUASCH, N., MORENO, G., GROUP, C.-S. W. & THE, L.-C.-I. 2022. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients. J Infect, 85, 374-381.

CASTLE, S., UYEMURA, K., RAFI, A., AKANDE, O. & MAKINODAN, T. 2005. Comorbidity Is a Better Predictor of Impaired Immunity than Chronological Age in Older Adults. Journal of the American Geriatrics Society, 53, 1565-9.

CATAÑO-CORREA, J. C., CARDONA-ARIAS, J. A., PORRAS MANCILLA, J. P. & GARCÍA, M. T. 2021. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PloS one, 16, e0254671.

CHEN, J. & GRIFFITHS, M. 1998. PCR differentiation of Escherichia coli from other Gram‐negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Letters in applied microbiology, 27, 369-371.

CHEN, T., WU, D., CHEN, H., YAN, W., YANG, D., CHEN, G., MA, K., XU, D., YU, H. & WANG, H. 2020. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj, 368.

CHENG, K., HE, M., SHU, Q., WU, M., CHEN, C. & XUE, Y. 2020. Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital. Risk Management and Healthcare Policy, 13, 2593.

CHRIST-CRAIN, M., STOLZ, D., BINGISSER, R., MULLER, C., MIEDINGER, D., HUBER, P. R., ZIMMERLI, W., HARBARTH, S., TAMM, M. & MULLER, B. 2006. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. American journal of respiratory and critical care medicine, 174, 84-93.

CONTOU, D., CLAUDINON, A., PAJOT, O., MICAËLO, M., FLANDRE, P. L., DUBERT, M., CALLY, R., LOGRE, E., FRAISSÉ, M. & MENTEC, H. 2020. Bacterial and viral co-infections in patients with severe SARSCoV-2 pneumonia admitted to a French ICU. Annals of Intensive Care, 10, 1-9.

COVINGTON, E. W., ROBERTS, M. Z. & DONG, J. 2018. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Pharmacotherapy, 38, 569-581.

DE BRUYN, A., VERELLEN, S., BRUCKERS, L., GEEBELEN, L., CALLEBAUT, I., DE PAUW, I., STESSEL, B. & DUBOIS, J. 2022. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation. BMC Infect Dis, 22, 207.

DE SMET, R., MELLAERTS, B., VANDEWINCKELE, H., LYBEERT, P., FRANS, E., OMBELET, S., LEMAHIEU, W., SYMONS, R., HO, E. & FRANS, J. 2020. Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study. Journal of the American Medical Directors Association, 21, 928-932. e1.

ELABBADI, A., TURPIN, M., GEROTZIAFAS, G. T., TEULIER, M., VOIRIOT, G. & FARTOUKH, M. 2021. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection, 49, 559-562.

ELTWISY, H. O., TWISY, H. O., HAFEZ, M. H., SAYED, I. M. & EL-MOKHTAR, M. A. 2022. Clinical Infections, Antibiotic Resistance, and Pathogenesis of Staphylococcus haemolyticus. Microorganisms, 10, 1130.

FALCONE, M., TISEO, G., GIORDANO, C., LEONILDI, A., MENICHINI, M., VECCHIONE, A., PISTELLO, M., GUARRACINO, F., GHIADONI, L. & FORFORI, F. 2021. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. Journal of Antimicrobial Chemotherapy, 76, 1078-1084.

FENG, X., LI, S., SUN, Q., ZHU, J., CHEN, B., XIONG, M. & CAO, G. 2020. Immune-inflammatory parameters in COVID-19 cases: a systematic review and metaanalysis. Frontiers in medicine, 7, 301.

GARCIA-VIDAL, C., SANJUAN, G., MORENO-GARCÍA, E., PUERTA-ALCALDE, P., GARCIA-POUTON, N., CHUMBITA, M., FERNANDEZ-PITTOL, M., PITART, C., INCIARTE, A. & BODRO, M. 2021. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection, 27, 83- 88.

GREEN, A. D. & LIDDY, M. A. 2020. Specimen Collection: Sputum by Suction (Respiratory Therapy). Elsevier.

GUAN, W. J., NI, Z. Y., HU, Y., LIANG, W. H., OU, C. Q., HE, J. X., LIU, L., SHAN, H., LEI, C. L., HUI, D. S. C., DU, B., LI, L. J., ZENG, G., YUEN, K. Y., CHEN, R. C., TANG, C. L., WANG, T., CHEN, P. Y., XIANG, J., LI, S. Y., WANG, J. L., LIANG, Z. J., PENG, Y. X., WEI, L., LIU, Y., HU, Y. H., PENG, P., WANG, J. M., LIU, J. Y., CHEN, Z., LI, G., ZHENG, Z. J., QIU, S. Q., LUO, J., YE, C. J., ZHU, S. Y. & ZHONG, N. S. 2020. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 382, 1708-1720.

HALL, G. S. 2013. Bailey & Scott’s Diagnostic microbiology, 13th edn. American Society for Clinical Pathology.

HANADA, S., PIRZADEH, M., CARVER, K. Y. & DENG, J. C. 2018. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Frontiers in immunology, 2640.

HASAN, N. S. & HOSHYAR, D. F. 2019. Detection of Enterotoxigenic Staphylococcus aureus Strains in Raw Milk of Cows Reared in Erbil Province/Iraq. ZANCO JOURNAL OF PURE AND APPLIED SCIENCES.

HE, S., LIU, W., JIANG, M., HUANG, P., XIANG, Z., DENG, D., CHEN, P. & XIE, L. 2021. Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study. PloS one, 16, e0249668.

HUANG, C., WANG, Y., LI, X., REN, L., ZHAO, J., HU, Y., ZHANG, L., FAN, G., XU, J. & GU, X. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395, 497-506.

HUI, D. S., AZHAR, E. I., MADANI, T. A., NTOUMI, F., KOCK, R., DAR, O., IPPOLITO, G., MCHUGH, T. D., MEMISH, Z. A. & DROSTEN, C. 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases, 91, 264-266.

KALOREY, D. R., SHANMUGAM, Y., KURKURE, N. V., CHOUSALKAR, K. K. & BARBUDDHE, S. B. 2007. PCR-based detection of genes encoding virulence determinants in Staphylococcus aureus from bovine subclinical mastitis cases. Journal of Veterinary Science, 8, 151-154.

KARATAŞ, M., YAŞAR-DUMAN, M., TÜNGER, A., ÇILLI, F., AYDEMIR, Ş. & ÖZENCI, V. 2021. Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of prepandemic and pandemic-era, a retrospective single center study. Annals of clinical microbiology and antimicrobials, 20, 1-8.

KHURANA, S., SINGH, P., SHARAD, N., KIRO, V. V., RASTOGI, N., LATHWAL, A., MALHOTRA, R., TRIKHA, A. & MATHUR, P. 2021. Profile of coinfections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian journal of medical microbiology, 39, 147-153.

LAI, C.-C., SHIH, T.-P., KO, W.-C., TANG, H.-J. & HSUEH, P.- R. 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents, 55, 105924.

LANGFORD, B. J., SO, M., RAYBARDHAN, S., LEUNG, V., WESTWOOD, D., MACFADDEN, D. R., SOUCY, J.-P. R. & DANEMAN, N. 2020. Bacterial co-infection and secondary infection in patients with COVID19: a living rapid review and meta-analysis. Clinical microbiology and infection, 26, 1622-1629.

LANSBURY, L., LIM, B., BASKARAN, V. & LIM, W. S. 2020. Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection, 81, 266-275.

LI, J., WANG, J., YANG, Y., CAI, P., CAO, J., CAI, X. & ZHANG, Y. 2020. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrobial Resistance & Infection Control, 9, 1-7.

LI, Z., HE, L., LI, S., HE, W., ZHA, C., OU, W., HOU, Q., WANG, W., SUN, X. & LIANG, H. 2019. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza. Influenza Other Respir Viruses, 13, 184-190.

MAHON, C. R., LEHMAN, D. C. & MANUSELIS, G. 2018. Textbook of diagnostic microbiology-e-book, Elsevier Health Sciences.

MANOHAR, P., LOH, B., NACHIMUTHU, R., HUA, X., WELBURN, S. C. & LEPTIHN, S. 2020. Secondary bacterial infections in patients with viral pneumonia. Frontiers in medicine, 7, 420.

MEGAHED, A. A., NASR, S. S. & MOHAMMED, G. 2015. Bacteriological and molecular detection of Pseudomonas species from raw milk sold in PortSaid Citymarkets. Egypt. J. Chem. Environ. Health, 1, 986-1002.

MEWES, J. C., PULIA, M. S., MANSOUR, M. K., BROYLES, M. R., NGUYEN, H. B. & STEUTEN, L. M. 2019. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis. PLoS One, 14, e0214222.

MICROBIOLOGY, N. 2020. Antimicrobial resistance in the age of COVID-19. Nat Microbiol, 5, 779.

MIRZAEI, R., GOODARZI, P., ASADI, M., SOLTANI, A., ALJANABI, H. A. A., JEDA, A. S., DASHTBIN, S., JALALIFAR, S., MOHAMMADZADEH, R. & TEIMOORI, A. 2020. Bacterial co‐infections with SARS‐CoV‐2. IUBMB life, 72, 2097-2111.

MONDAL, U. K., HAQUE, T., BISWAS, M. A. A. J., SATTER, S. M., ISLAM, M. S., ALAM, Z., SHOJON, M., DEBNATH, S., ISLAM, M., MURSHID, H. B., HASSAN, M. Z. & HOMAIRA, N. 2022. Antibiotic Prescribing Practices for Treating COVID-19 Patients in Bangladesh. Antibiotics, 11, 1350.

MORENS, D. M., TAUBENBERGER, J. K. & FAUCI, A. S. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. The Journal of infectious diseases, 198, 962-970.

MORRIS, D. E., CLEARY, D. W. & CLARKE, S. C. 2017. Secondary bacterial infections associated with influenza pandemics. Frontiers in microbiology, 8, 1041.

NORI, P., COWMAN, K., CHEN, V., BARTASH, R., SZYMCZAK, W., MADALINE, T., KATIYAR, C. P., JAIN, R., ALDRICH, M. & WESTON, G. 2021. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infection Control & Hospital Epidemiology, 42, 84-88.

OPAL, S. M., GIRARD, T. D. & ELY, E. W. 2005. The immunopathogenesis of sepsis in elderly patients. Clinical infectious diseases, 41, S504-S512.

ORGANIZATION, W. H. 2020. Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic: interim guidance, May 2020. World Health Organization.

PINCUS, D. H. 2006. Microbial identification using the bioMérieux Vitek® 2 system. Encyclopedia of Rapid Microbiological Methods. Bethesda, MD: Parenteral Drug Association, 1-32.

POURAJAM, S., KALANTARI, E., TALEBZADEH, H., MELLALI, H., SAMI, R., SOLTANINEJAD, F., AMRA, B., SAJADI, M., ALENASERI, M., KALANTARI, F. & SOLGI, H. 2022. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic. Front Cell Infect Microbiol, 12, 784130.

QIN, C., ZHOU, L., HU, Z., ZHANG, S., YANG, S., TAO, Y., XIE, C., MA, K., SHANG, K. & WANG, W. 2020. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases, 71, 762-768.

RICHARDS, O., PALLMANN, P., KING, C., CHEEMA, Y., KILLICK, C., THOMAS-JONES, E., HARRIS, J., BAILEY, C. & SZAKMANY, T. 2021. Procalcitonin Increase Is Associated with the Development of Critical Care Acquired Infections in COVID-19 ARDS. Antibiotics (Basel), 10.

RIPA, M., GALLI, L., POLI, A., OLTOLINI, C., SPAGNUOLO, V., MASTRANGELO, A., MUCCINI, C., MONTI, G., DE LUCA, G., LANDONI, G., DAGNA, L., CLEMENTI, M., ROVERE QUERINI, P., CICERI, F., TRESOLDI, M., LAZZARIN, A., ZANGRILLO, A., SCARPELLINI, P., CASTAGNA, A. & GROUP, C. O.-B. S. 2021. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect, 27, 451-457.

Acquired Infections in COVID-19 ARDS. Antibiotics (Basel), 10. RIPA, M., GALLI, L., POLI, A., OLTOLINI, C., SPAGNUOLO, V., MASTRANGELO, A., MUCCINI, C., MONTI, G., DE LUCA, G., LANDONI, G., DAGNA, L., CLEMENTI, M., ROVERE QUERINI, P., CICERI, F., TRESOLDI, M., LAZZARIN, A., ZANGRILLO, A., SCARPELLINI, P., CASTAGNA, A. & GROUP, C. O.-B. S. 2021. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect, 27, 451-457.

SANTOSO, P., SUNG, M., HARTANTRI, Y., ANDRIYOKO, B., SUGIANLI, A. K., ALISJAHBANA, B., TJIAM, J. S. L., DEBORA, J., KUSUMAWATI, D. & SOEROTO, A. Y. 2022. MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia. Int J Gen Med, 15, 4741- 4751

SEATON, R. A., GIBBONS, C. L., COOPER, L., MALCOLM, W., MCKINNEY, R., DUNDAS, S., GRIFFITH, D., JEFFREYS, D., HAMILTON, K., CHOO-KANG, B., BRITTAIN, S., GUTHRIE, D. & SNEDDON, J. 2020. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect, 81, 952-960

SHARIFIPOUR, E., SHAMS, S., ESMKHANI, M., KHODADADI, J., FOTOUHI-ARDAKANI, R., KOOHPAEI, A., DOOSTI, Z. & EJ GOLZARI, S. 2020. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC infectious diseases, 20, 1-7.

SHI, M. M., MONSEL, A., ROUBY, J. J., XU, Y. P., ZHU, Y. G. & QU, J. M. 2019. Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus. Front Microbiol, 10, 2198.

SHIMPOH, T., HIRATA, Y., IHARA, S., SUZUKI, N., KINOSHITA, H., HAYAKAWA, Y., OTA, Y., NARITA, A., YOSHIDA, S. & YAMADA, A. 2017. Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer. Gut pathogens, 9, 1-8.

TAHA, S. I., SHATA, A. K., BAIOUMY, S. A., FOUAD, S. H., MOUSSA, A. H., EL-SEHSAH, E. M., SALLAM, D. & YOUSSEF, M. K. 2022. The Clinical Utility of Serial Procalcitonin and Procalcitonin Clearance in Predicting the Outcome of COVID-19 Egyptian Patients. Afro-Egyptian Journal of Infectious and Endemic Diseases, 12, 115-123.

TURTON, J. F., WOODFORD, N., GLOVER, J., YARDE, S., KAUFMANN, M. E. & PITT, T. L. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol, 44, 2974-6.

USMAN, M., FAROOQ, M. & HANNA, K. 2020. Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19. Science of the Total Environment, 745, 141053.

VIJAY, S., BANSAL, N., RAO, B. K., VEERARAGHAVAN, B., RODRIGUES, C., WATTAL, C., GOYAL, J. P., TADEPALLI, K., MATHUR, P., VENKATESWARAN, R., VENKATASUBRAMANIAN, R., KHADANGA, S., BHATTACHARYA, S., MUKHERJEE, S., BAVEJA, S., SISTLA, S., PANDA, S. & WALIA, K. 2021. Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience. Infect Drug Resist, 14, 1893- 1903.

WANG, D., HU, B., HU, C., ZHU, F., LIU, X., ZHANG, J., WANG, B., XIANG, H., CHENG, Z. & XIONG, Y. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323, 1061- 1069.

WAYNE, P. 2007. Principles and procedures for blood cultures; approved guideline, CLSI document M47- A. Clinical and Laboratory Standards Institute (CLSI).

WAYNE, P. 2019. Clinical and Laboratory Standard Institute: Performance standards for antimicrobial susceptiblity testing: 29th information supplement. CLSI document M100-S29.

WORLD HEALTH ORGANIZATION. 2022. WHO Coronavirus disease( COVID-19) dashboard [Online]. Available: https://covid19.who.int/ [Accessed].

WORLDOMETER. 2022. COVID-19 pandemic in Iraq [Online]. Available: https://www.worldometers.info/coronavirus/cou ntry/iraq/ [Accessed].

ZHANG, H., ZHANG, Y., WU, J., LI, Y., ZHOU, X., LI, X., CHEN, H., GUO, M., CHEN, S. & SUN, F. 2020. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerging microbes & infections, 9, 1958-1964.

ZHOU, F., YU, T., DU, R., FAN, G., LIU, Y., LIU, Z., XIANG, J., WANG, Y., SONG, B. & GU, X. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395, 1054-1062.

ZHU, Y., YUAN, Y. & HUANG, H. 2015. Comparison of serum procalcitonin in respiratory infections and bloodstream infections. International Journal of Clinical and Experimental Medicine, 8, 21586.

Publication Date

9-1-2023

Download

Included in

Biology Commons

Share

COinS